Evidence map›Paper›PMID 29162652›Full record

ArticleCold Spring Harbor molecular case studies2017

Elucidating the pathogenesis of synchronous and metachronous tumors in a woman with endometrioid carcinomas using a whole-exome sequencing approach.

Ren-Chin Wu, Ema Veras, Jeffrey Lin, Emily Gerry, Asli Bahadirli-Talbott, Alexander Baras, Ayse Ayhan, Ie-Ming Shih, Tian-Li Wang

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. The Origin and Pathogenesis of Endometriosis.Annual review of pathology · 2020
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 3 countries.

Ren-Chin WuDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.ORCID http://orcid.org/0000-0003-1439-0874
Ema VerasDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Jeffrey LinDepartment of Gynecology & Obstetrics, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Emily GerryDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Asli Bahadirli-TalbottDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Alexander BarasDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Ayse AyhanDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Ie-Ming ShihDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Tian-Li WangDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.
Johns Hopkins University · USHiroshima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synchronous endometrial and ovarian (SEO) carcinomas involve endometrioid neoplasms in both the ovary and uterus at the time of diagnosis. Patients were traditionally classified as having independent primary SEO lesions or as having metastatic endometrioid carcinoma. Recent studies have supported that SEO tumors result from the dissemination of cells from one organ site to another. However, whether this can be considered a "metastasis" or "dissemination" remains unclear. In this report, we performed whole-exome sequencing of tumor samples from a woman with well-differentiated endometrioid SEO tumors and a clinical "recurrent" poorly differentiated peritoneal tumor that was diagnosed 8 years after the complete resection of the SEO tumors. Somatic mutation analysis identified 132, 171, and 1214 nonsynonymous mutations in the endometrial, ovarian, and peritoneal carcinomas, respectively. A unique mutation signature associated with mismatch repair deficiency was observed in all three tumors. The SEO carcinomas shared 57 nonsynonymous mutations, whereas the clinically suspected recurrent carcinoma shared only eight nonsynonymous mutations with the SEO tumors. One of the eight shared somatic mutations involved

Indexed as

Carcinoma, Ovarian EpithelialClone CellsDNA Mutational AnalysisEndometrial NeoplasmsExome SequencingFemaleHumansINDEL MutationLoss of HeterozygosityMiddle AgedMutationNeoplasm Recurrence, LocalNeoplasms, Glandular and EpithelialNeoplasms, Multiple PrimaryNeoplasms, Second PrimaryOvarian NeoplasmsPTEN PhosphohydrolasePTEN protein, humanendometrial carcinomaendometriosisovarian neoplasm

Identifiers

PMID29162652
PMCPMC5701312
OpenAlexW2768955837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.